Late treatment study
Yanrong, deputy head of the China National Center for Biotechnology Development (News) (not included in the study count)
Antimalarial drug confirmed effective on COVID-19
HC Q under clinical trials in >10 hospitals in China and has shown fairly good efficacy.
Currently no formal study is available so this is not included in the study count.
Please send us corrections, updates, or comments.